» Authors » Jungang Chen

Jungang Chen

Explore the profile of Jungang Chen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 42
Citations 331
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen J, Fan J, Malaviarachchi P, Post S, Lin Z, Zhang X, et al.
J Med Virol . 2024 Dec; 97(1):e70149. PMID: 39740042
An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 pandemic, has resulted in over 7 million confirmed deaths. In addition to severe respiratory and systematic symptoms, several...
2.
Wang Z, Zhou G, Chen J, Miao X, Xia Y, Du Z, et al.
PLoS One . 2024 Dec; 19(12):e0316178. PMID: 39724209
Agarwood is a precious resinous heartwood highly valued for its cultural, religious, and medicinal significance. With the increasing market demand, natural agarwood resources are rapidly depleting, making the development of...
3.
Chen J, Lin Z, Fan J, Monzavi-Karbassi B, Kelly T, Post S, et al.
Am J Cancer Res . 2024 May; 14(4):1545-1560. PMID: 38726264
Breast cancer represents the leading cancer type and leading cause of cancer-related death among women in the world. Triple-negative breast cancer (TNBC) is a subset of breast cancer with the...
4.
Chen J, Fan J, Lin Z, Dai L, Qin Z
J Med Virol . 2024 Mar; 96(3):e29534. PMID: 38501356
Human endogenous retrovirus sequences (HERVs) constitute up to 8% of the human genome, yet not all HERVs remain silent passengers within our genomes. Some HERVs, especially the HERV type K...
5.
Chen J, Lin Z, Song J, Plaisance-Bonstaff K, James J, Mu S, et al.
J Hematol Oncol . 2023 May; 16(1):48. PMID: 37143124
Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiologic agent of several human cancers, including Kaposi's sarcoma (KS) and primary effusion lymphoma (PEL), which preferentially arise in immunocompromised patients while lack of...
6.
Chen J, Song J, Plaisance-Bonstaff K, Mu S, Post S, Dai L, et al.
Viruses . 2023 Apr; 15(4). PMID: 37112991
Although Kaposi's sarcoma-associated herpesvirus (KSHV) has been reported to cause several human cancers including Kaposi's sarcoma (KS) and primary effusion lymphoma (PEL), the mechanisms of KSHV-induced tumorigenesis, especially virus-host interaction...
7.
Wang S, Xu S, Ye F, Zhu C, Yu Y, Chen J
Anticancer Drugs . 2023 Feb; 34(7):888-891. PMID: 36730073
Anaplastic lymphoma kinase ( ALK ) rearrangements are one of the most common mutations in nonsmall cell lung cancer. Majority of the ALK rearrangements were sensitive to crizotinib, yet some...
8.
Chen J, Wang Z, Phuc T, Xu Z, Yang D, Chen Z, et al.
PLoS Pathog . 2023 Jan; 19(1):e1011089. PMID: 36638143
Primary effusion lymphoma (PEL) caused by Kaposi sarcoma-associated herpesvirus (KSHV) is an aggressive malignancy with poor prognosis even under chemotherapy. Currently, there is no specific treatment for PEL therefore requiring...
9.
Chen J, Song J, James J, Plaisance-Bonstaff K, Post S, Qin Z, et al.
Front Cell Infect Microbiol . 2022 Dec; 12:1049624. PMID: 36457850
Objective: Kaposi's Sarcoma-associated Herpesvirus (KSHV) is the etiologic agent of several human cancers, including Kaposi's sarcoma (KS) and Primary effusion lymphoma (PEL), which are usually seen in immunocompromised patients while...
10.
Sun W, Chen J, Yan L, Lin J, Pang Y, Zhang G
Front Physiol . 2022 Sep; 13:981463. PMID: 36072854
Owing to its significant contagion and mutation, the new crown pneumonia epidemic has caused more than 520 million infections worldwide and has brought irreversible effects on the society. Computed tomography...